Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Cancer Causes Control. 2019 Nov 28;31(1):85–93. doi: 10.1007/s10552-019-01248-1

Table 2.

The proportion of renal cell cancer incidence attributable a to hypertension and CKD among adults age 50 years or older by race and sex in the USKC and KPNC studies.

USKC
KPNC
Exposure Sex/Race PAR% (95%CI) P-valueb PAR%(95%CI) P-valueb
Hypertension Female
 White 28.5 (13.4, 43.6) 0.14 27.4 (20.3, 34.5) 0.31
 Black 50.1 (23.5, 76.7) 39.8 (17.5, 62.2)
Male
 White 26.6 (14.2, 39.0) 0.13 18.9 (13.7, 24.1) 0.72
 Black 44.4 (24.7, 64.1) 22.8 (1.6, 44.1)
CKD Female
 White 0.4 (−1.5, 2.3) 0.02 −0.3 (−0.8, 0.1) 0.009
 Black 8.4 (1.9, 14.9) 6.9 (1.5, 12.4)
Male
 White 0.6 (−0.5, 1.6) 0.002 0.0 (−0.6, 0.5) 0.0003
 Black 9.4 (4.0, 14.8) 10.1 (4.6, 15.5)
CKD or hypertension Female
 White 29.7 (15.0, 44.4) 0.15 27.2 (20.0, 34.4) 0.17
 Black 51.2 (25.6, 76.8) 43.0 (22.2, 63.8)
Male
 White 27.0 (14.7, 39.3) 0.04 18.9 (13.7, 24.1) 0.28
 Black 49.2 (32.0, 66.3) 29.4 (10.5, 48.3)

Abbreviations: USKC, US Kidney Cancer Study; KPNC, Kaiser Permanente Northern California; PAR, population attributable risk; CI, confidence interval; CKD, chronic kidney disease.

a

USKC PAR% were calculated from unconditional sample weighted logistic regression models, adjusted for hypertension, CKD, body mass index, smoking status, education, age, study center and family history of cancer. KPNC PAR% were calculated using conditional logistic regression models, conditioned on the matched sets and adjusted for hypertension, CKD, smoking status, and diabetes.

b

P-value estimated from two sample t-test of difference by race.